Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?

Guidotti, Luca G; La Vecchia, Carlo; Colombo, Massimo

Guidotti, Luca G; La Vecchia, Carlo; Colombo, Massimo.

Afiliación

Guidotti LG; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
La Vecchia C; Vita-Salute San Raffaele University, Milan, Italy.
Colombo M; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Hepatology ; 76(2): 300-302, 2022 08.

Article en En | MEDLINE | ID: mdl-35254662

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Aspirina/uso terapéutico; Carcinoma Hepatocelular/etiología; Carcinoma Hepatocelular/prevención & control; Virus de la Hepatitis B; Humanos; Cirrosis Hepática; Neoplasias Hepáticas/etiología; Neoplasias Hepáticas/prevención & control; Factores de Riesgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google